Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
about
The future of multiple sclerosis treatments.Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions.Advances and insights into neurological practice 2016-17.Science is 1% inspiration and 99% biomarkers.Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
P2860
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@en
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@nl
type
label
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@en
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@nl
prefLabel
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@en
Cerebrospinal fluid chitinase- ...... s in early multiple sclerosis.
@nl
P2093
P2860
P356
P1476
Cerebrospinal fluid chitinase- ...... rs in early multiple sclerosis
@en
P2093
J L Frederiksen
M Møllgaard
P2860
P304
P356
10.1111/ENE.12960
P577
2016-02-12T00:00:00Z